{
    "organizations": [],
    "uuid": "253174f2611808bd6ab8c1861648736a0e292670",
    "author": "",
    "url": "https://www.reuters.com/article/brief-iovance-announces-preliminary-phas/brief-iovance-announces-preliminary-phase-2-data-for-til-treatment-in-head-and-neck-and-cervical-cancers-idUSFWN1PJ1CW",
    "ord_in_thread": 0,
    "title": "BRIEF-Iovance Announces Preliminary Phase 2 Data For Til Treatment In Head And Neck And Cervical Cancers",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 24 (Reuters) - Iovance Biotherapeutics Inc:\n* IOVANCE BIOTHERAPEUTICS ANNOUNCES PRELIMINARY PHASE 2 DATA FOR TIL TREATMENT IN HEAD AND NECK AND CERVICAL CANCERS\n* 3 OF 8 PATIENTS TREATED WITH LN-145 HAD REDUCTION IN TUMOR SIZE OF AT LEAST 30 PCT & QUALIFIED AS PARTIAL RESPONSE\n* 1 OF 2 EVALUABLE PATIENTS WITH RECURRENT, METASTATIC/PERSISTENT CERVICAL CARCINOMA TREATED WITH LN-145 EXPERIENCED CONFIRMED PARTIAL RESPONSE WILL CONTINUE TO ENROLL PATIENTS IN STUDY TO FULL SAMPLE SIZE OF 47 PER PROTOCOL\n* ONE PATIENT TREATED WITH LN-145 HAD A CONFIRMED PR AND ONE HAD STABLE DISEASE AS PER PRELIMINARY DATA FROM C-145-04 STUDY\n* REPORTED PRELIMINARY CLINICAL RESULTS FROM TWO ONGOING OPEN-LABEL PHASE 2 STUDIES IN HEAD AND NECK AND CERVICAL CANCERS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-25T00:06:00.000+02:00",
    "crawled": "2018-01-25T00:23:08.016+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "iovance",
        "biotherapeutics",
        "inc",
        "iovance",
        "biotherapeutics",
        "announces",
        "preliminary",
        "phase",
        "data",
        "til",
        "treatment",
        "head",
        "neck",
        "cervical",
        "cancer",
        "patient",
        "treated",
        "reduction",
        "tumor",
        "size",
        "least",
        "pct",
        "qualified",
        "partial",
        "response",
        "evaluable",
        "patient",
        "recurrent",
        "cervical",
        "carcinoma",
        "treated",
        "experienced",
        "confirmed",
        "partial",
        "response",
        "continue",
        "enroll",
        "patient",
        "study",
        "full",
        "sample",
        "size",
        "per",
        "protocol",
        "one",
        "patient",
        "treated",
        "confirmed",
        "pr",
        "one",
        "stable",
        "disease",
        "per",
        "preliminary",
        "data",
        "study",
        "reported",
        "preliminary",
        "clinical",
        "result",
        "two",
        "ongoing",
        "phase",
        "study",
        "head",
        "neck",
        "cervical",
        "cancer",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}